Concepedia

R F Brinkhuis

RF

Statistics

Publications

3

Citations

789

H-Index

3

Active since

1999

Affiliations

The Netherlands Cancer Institute(Current)

R F Brinkhuis is an author at The Netherlands Cancer Institute specializing in molecular oncology, pharmacology, and oncology.

Publications per year

1999–2003

3

Publications

3

The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin.

John Allen, R F Brinkhuis, Jan Wijnholds et al. · PubMed · 1999 · 352 citations

, , +17

The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Antonius E. van Herwaarden, Johan W. Jonker, Els Wagenaar et al. · PubMed · 2003 · 237 citations

, , +14

Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance.

John Allen, R F Brinkhuis, Liesbeth van Deemter et al. · PubMed · 2000 · 200 citations

, , +15

1–3 of 3